Vanderbilt University partners with ACADIA Pharmaceuticals to develop novel treatments for central nervous system disorders
Jun. 16, 2020—Vanderbilt University’s Warren Center for Neuroscience Drug Discovery has entered into an exclusive worldwide licensing and collaboration agreement with San Diego-based ACADIA Pharmaceuticals Inc. to develop treatments for disorders like Alzheimer’s and schizophrenia.
Oct. 10, 2019—Interim Chancellor and Provost Susan R. Wente and Louise B. McGavock Professor of Cell and Developmental Biology Ian Macara have been elected 2019 fellows of the American Society for Cell Biology.
May. 3, 2019—Vanderbilt University Board of Trust Chairman Bruce R. Evans has appointed a Chancellor Search Advisory Committee to assist in the search for the university’s ninth chancellor.
Feb. 27, 2019—Sandra Rosenthal will step down as director of the Vanderbilt Institute for Nanoscale Science and Engineering on June 30 following 12 years of service.
Aug. 29, 2018—A $1 million gift has established a new faculty chair within the School of Medicine’s Basic Sciences that is named in honor of the late biochemist Richard Armstrong.
Aug. 21, 2018—Dr. Nancy Carrasco, a leading figure in the study of iodide transport and its critical role in the thyroid and mammary glands, has been named chair of Vanderbilt's Department of Molecular Physiology and Biophysics.
Sep. 14, 2017—Ian Macara, Ph.D., left, chair of the Department of Cell and Developmental Biology, and Lawrence Marnett, Ph.D., right, dean of Basic Sciences in the School of Medicine, visited with Rockefeller University professor David Allis, Ph.D., last week prior to Allis’ Flexner Discovery Lecture on epigenetics.
Apr. 13, 2017—Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year.